Evidence map›Paper›PMID 35785076›Full record

ArticleComputational intelligence and neuroscience2022

A Novel Hybrid Deep Learning Model for Metastatic Cancer Detection.

Shahab Ahmad, Tahir Ullah, Ijaz Ahmad, Abdulkarem Al-Sharabi, Kalim Ullah, Rehan Ali Khan, Saim Rasheed, Inam Ullah, Md Nasir Uddin, Md Sadek Ali

Abstract read
In one paragraph

Article in Computational intelligence and neuroscience, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. On the Analyses of Medical Images Using Traditional Machine Learning Techniques and Convolutional Neural Networks.Archives of computational methods in engineering : state of the art reviews · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shahab AhmadSchool of Management Science and Engineering, Chongqing University of Post and Telecommunication, Chongqing 400065, China.
Tahir UllahDepartment of Electronics and Information Engineering, Xian Jiaotong University, Xian, China.
Ijaz AhmadShenzhen College of Advanced Technology, University of Chinese Academy of Sciences, Shenzhen 518055, China.ORCID https://orcid.org/0000-0003-3974-2207
Abdulkarem Al-SharabiDalian Medical College and University, Dalian 116044, China.
Kalim UllahDepartment of Zoology, Kohat University of Science and Technology, Kohat 26000, Pakistan.
Rehan Ali KhanDepartment of Electrical Engineering, University of Science and Technology, Bannu 28100, Pakistan.ORCID https://orcid.org/0000-0001-8917-9278
Saim RasheedDepartment of Information Technology, Faculty of Computing and Information Technology, King Abdulaziz University Jeddah, Saudi Arabia.
Inam UllahCollege of Internet of Things (IoT) Engineering, Hohai University (HHU), Changzhou Campus, Nanjing 213022, China.ORCID https://orcid.org/0000-0002-5879-569X
Md Nasir UddinCommunication Research Laboratory, Department of Information and Communication Technology, Islamic University, Kushtia 7003, Bangladesh.
Md Sadek AliCommunication Research Laboratory, Department of Information and Communication Technology, Islamic University, Kushtia 7003, Bangladesh.ORCID https://orcid.org/0000-0001-6253-5519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer has been found as a heterogeneous disease with various subtypes and aims to destroy the body's normal cells abruptly. As a result, it is essential to detect and prognosis the distinct type of cancer since they may help cancer survivors with treatment in the early stage. It must also divide cancer patients into high- and low-risk groups. While realizing efficient detection of cancer is frequently a time-taking and exhausting task with the high possibility of pathologist errors and previous studies employed data mining and machine learning (ML) techniques to identify cancer, these strategies rely on handcrafted feature extraction techniques that result in incorrect classification. On the contrary, deep learning (DL) is robust in feature extraction and has recently been widely used for classification and detection purposes. This research implemented a novel hybrid AlexNet-gated recurrent unit (AlexNet-GRU) model for the lymph node (LN) breast cancer detection and classification. We have used a well-known Kaggle (PCam) data set to classify LN cancer samples. This study is tested and compared among three models: convolutional neural network GRU (CNN-GRU), CNN long short-term memory (CNN-LSTM), and the proposed AlexNet-GRU. The experimental results indicated that the performance metrics accuracy, precision, sensitivity, and specificity (99.50%, 98.10%, 98.90%, and 97.50) of the proposed model can reduce the pathologist errors that occur during the diagnosis process of incorrect classification and significantly better performance than CNN-GRU and CNN-LSTM models. The proposed model is compared with other recent ML/DL algorithms to analyze the model's efficiency, which reveals that the proposed AlexNet-GRU model is computationally efficient. Also, the proposed model presents its superiority over state-of-the-art methods for LN breast cancer detection and classification.

Indexed as

Breast NeoplasmsDeep LearningAlgorithmsFemaleHumansMachine LearningNeural Networks, Computer

Identifiers

PMID35785076
PMCPMC9249449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.